This inventor holds 18 USPTO granted patents and 6 published patent applications and 8 EPO patents. Top assignee: Genomictree, Inc.. Active years: 2016-2022.
Company Filing History:
Years Active: 2016-2022
Title: Innovations in Cancer Diagnosis: The Contributions of Sung Whan An
Introduction
Sung Whan An, an esteemed inventor based in Daejeon, Korea, has made significant contributions to the field of medical diagnostics. With a remarkable portfolio of 18 patents, An's work primarily focuses on developing innovative methods for detecting various types of cancer, harnessing the power of molecular biology to enhance diagnosis and patient outcomes.
Latest Patents
Among An's latest inventions is a groundbreaking method for detecting the methylation of colorectal-cancer-specific marker genes, particularly targeting the SDC2 (Syndecan 2) gene. This method aims to improve colorectal cancer diagnostics by accurately identifying specific methylation patterns associated with the disease. Additionally, he has developed a method for detecting lung cancer using a specific methylation marker gene, PCDHGA12, which has proven to facilitate early detection and understanding of lung cancer progression. These patented technologies signify substantial advancements in early cancer detection and prognosis.
Career Highlights
Sung Whan An currently operates as a pivotal member of Genomictree, Inc., where he applies his innovative mindset to combatting cancer through improved diagnostic methodologies. His dedication to research and invention is evident in the functionality and significance of his patented technologies, which demonstrate potential for real-world application in clinical settings.
Collaborations
Throughout his career, An has collaborated with esteemed colleagues, including Tae Jeong Oh and Young Ho Moon. These partnerships have fostered a collaborative environment that encourages innovative healthcare solutions and advancements in the field of oncology.
Conclusion
Sung Whan An's contributions to cancer diagnostics reflect a profound commitment to scientific innovation and public health. His patents not only advance the technological landscape of cancer detection but also hold promise for improving patient care and outcomes. As he continues to innovate within Genomictree, Inc., An stands as an exemplary figure in the realm of medical inventions, inspiring future advancements in the fight against cancer.